Icecure Medical Ltd expected to post a loss of 8 cents a share - Earnings Preview

Icecure Medical

26/05/2025 13:34

Icecure Medical Ltd ICCM.OQ ICCM.O is expected to show a rise in quarterly revenue when it reports  results on May 28 for the period ending March 31 2025

The Caesarea Israel-based   company is expected to report a 0.9% increase in revenue to $750 thousand from $743 thousand a year ago, according to the mean estimate from 2 analysts, based on LSEG data.

​LSEG's mean analyst estimate for Icecure Medical Ltd is for a loss of 8 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Icecure Medical Ltd is $3.00​, above​ its last closing price of $1.06. ​​​

This summary was machine generated May 26 at 12:34 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)